Data / Form D filings / IMMvention Therapeutix, Inc.
IMMvention Therapeutix, Inc.: Form D filings
IMMvention Therapeutix, Inc., a biotechnology company in Durham, NC, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on January 10, 2023, reports $2 million sold of a $4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9 Laboratory Drive, Suite 264, Durham, NC, 27709
- Phone
- (919) 593-6230
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1837999
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | New notice | $3,999,999 | $1,999,999 | $2,000,000 | 4 | Dec 23, 2022 | sec.gov |
| Nov 19, 2021 | Amendment | $6,899,999 | $6,899,999 | 5 | Dec 7, 2020 | sec.gov | |
| Dec 28, 2020 | New notice | $4,402,504 | $3,902,502 | $500,002 | 4 | Dec 7, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jenny Ting | Director | |
| Marilyn Thompson | Executive Officer | |
| Mark Velleca | Director | |
| Anil Goyal | Executive Officer, Director | |
| Lev Osherovich | Director | |
| Benjamin Scruggs | Director | |
| Matthew Cohen | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jan 9, 2023 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IMMvention Therapeutix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.